Inactief instrument

Koers Onyx Pharmaceuticals, Inc.

Aandelen

slotkoers Nasdaq Andere beurzen
- ^USD	-

Onyx Pharmaceuticals : Amgen Receives CHMP Positive Opinions for Two New Treatment Options for Patients with Blood Cancer in Europe	01-10-15
Onyx Pharmaceuticals : Amgen Submits Supplemental New Drug Application for Kyprolis® (Carflizomib) in Relapsed Multiple Myeloma	23-07-15
Onyx Pharmaceuticals : Amgen Initiates Phase 3 Study Evaluating Once-Weekly Kyprolis® (Carflizomib) in Patients with Relapsed and Refractory Multiple Myeloma	31-05-15
Onyx Pharmaceuticals : Amgen to Advance Understanding of the Treatment of Blood Cancers at the 20th Congress of European Hematology Association (EHA)	27-05-15
Onyx Pharmaceuticals : Amgen Data at ASCO 2015 Highlight Oncology Pipeline and Portfolio	13-05-15

Sector

	Vaira. 1 jan.	Kapi.
VERTEX PHARMACEUTICALS INCORPORATED	-2,31%	103 mld.
REGENERON PHARMACEUTICALS, INC.	+0,56%	95,28 mld.
ARGENX SE	+1,69%	22,15 mld.
BIONTECH SE	-17,37%	21,02 mld.
GENMAB A/S	-9,30%	18,15 mld.
WUXI APPTEC CO., LTD.	-41,01%	16,74 mld.
BEIGENE, LTD.	-14,85%	16,05 mld.
NEUROCRINE BIOSCIENCES, INC.	+3,21%	13,68 mld.
SAREPTA THERAPEUTICS, INC.	+33,54%	12,17 mld.